SearchDictionaryMobileLogin

Hashimoto Disease (Thyroiditis, Hashimoto)

415  relevant articles (8 outcomes, 25 trials/studies) found for this Disease

Description: Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.

Also Known As:
Thyroiditis, Hashimoto; Hashimotos Disease; Hashimoto's Disease; Chronic Lymphocytic Thyroiditis; Hashimoto Thyroiditis; Chronic Lymphocytic Thyroiditides; Disease, Hashimoto; Disease, Hashimoto's; Hashimoto Thyroiditides; Lymphocytic Thyroiditides, Chronic; Lymphocytic Thyroiditis, Chronic; Thyroiditides, Chronic Lymphocytic; Thyroiditides, Hashimoto; Thyroiditis, Chronic Lymphocytic

Relationship Network

Disease Context: Research Results

Related Diseases

1. Graves Disease (Basedow Disease)
2. Hypothyroidism
3. Thyroid Diseases (Thyroid Disease)
4. Diabetes Mellitus
5. Thyrotoxicosis

Experts

1. Watanabe, Mikio: 3 articles (03/2008 - 09/2002)
2. Iwatani, Yoshinori: 3 articles (03/2008 - 09/2002)
3. Lewiński, Andrzej: 2 articles (06/2003 - 08/2002)
4. Karbownik, Małgorzata: 2 articles (06/2003 - 08/2002)
5. Zasada, Krzysztof: 2 articles (06/2003 - 08/2002)
6. Shabb, Nina S: 1 article (09/2008)
7. Szodoray, Peter: 1 article (09/2008)
8. Horvath, Ildiko: 1 article (09/2008)
9. Salti, Ibrahim S: 1 article (09/2008)
10. Zhang, De-Liang: 1 article (09/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hashimoto Disease:
1. AntibodiesIBA
2. Thyrotropin Receptors (Thyrotropin Receptor)IBA
3. Thyroxine (Levothyroxine)FDA LinkGeneric
4. HormonesIBA
5. ThyroglobulinFDA Link
6. Immunoglobulin G (IgG)IBA
08/01/1989 - "Both titre and affinity of IgG3 and IgG2 anti-Tg were generally low but in some Hashimoto's disease patients high-affinity IgG2 anti-Tg were found and IgG2 anti-Tg, unlike those of other subclasses, showed very restricted heterogeneity. "
11/01/1990 - "This IgG may be involved in the mechanism that causes hypothyroidism in some patients with goitrous Hashimoto's disease."
06/01/1986 - "To the Triton-solubilized FCM crosslinked with 125I-TSH, 50 micrograms each of IgG from 20 normal controls, 20 patients with Graves' disease and 20 with Hashimoto's disease was added and precipitation was effected by adding anti-human IgG. In patients with Graves' disease, 125I-TSH-FCM complexes immunoprecipitated ranged from 1.10 to 4.18% with an average of 2.4 +/- 0.99 (S. "
01/01/1986 - "IgG from 2 hypothyroid patients with Hashimoto's disease, which were strongly positive in the TSH binding inhibition (TBI) assay, yielded FBI values within the range in Graves' disease, but values in TBI-negative IgG from 15 other patients with Hashimoto's disease were normal (0.0 +/- 0.9). "
08/01/1989 - "In contrast, a progressive increase in IgG1 anti-Tg affinity was seen in clinically euthyroid individuals compared with their relatives with thyroid disease and high titred Hashimoto's disease patients, suggesting that either rising titres of high affinity IgG1 anti-Tg or affinity maturation of IgG1 anti-Tg may be indicative of impending hypothyroidism."
Order ALL the reference details at left...
7. HLA-DR Antigens (HLA-DR)IBA
8. Insulin ReceptorIBA
9. CortisoneIBA
10. Factor IX (PTC)FDA LinkGeneric

Therapies and Procedures

1. Thyroidectomy
2. Lasers (Laser)
3. Thymectomy
4. Drug Therapy (Chemotherapy)
5. Investigational Therapies (Experimental Therapy)

Best Treatments:
Research Summary Report
on Hashimoto Disease
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 8 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>